What Researchers Did
Researchers investigated the effects of hyperbaric oxygen (HBO) therapy, alone or combined with chemotherapy and radiotherapy, on glioblastoma (GBM) cells and tumors in laboratory and animal models.
What They Found
Researchers found that HBO therapy did not affect GBM cell viability but reduced the tumors' ability to form cancer stem cells. It also increased GBM sensitivity to temozolomide and radiotherapy in both laboratory and animal models, showing adjuvant effects by inhibiting GBM stemness without enhancing tumor growth.
What This Means for Canadian Patients
Hyperbaric oxygen therapy may offer a new way to enhance the effectiveness of current glioblastoma treatments like chemotherapy and radiotherapy. This could potentially improve outcomes for Canadian patients facing this aggressive brain cancer by targeting cancer stem cells.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
This study was conducted using in vitro and in vivo models, meaning its findings require further validation in human clinical trials.